One study showed successful labeling with the use of an anti-human monoclonal AXL antibody radiolabelled with I125 via SPECT/CT imaging in mice xenografted with AXL-high and AXL-low pancreatic and prostate cancer cell lines and uptake appeared to correlate closely with IHC findings. Here, AXL is linked to prostate cancer.